Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT942626RE023
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
Q301
Additional Details
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a combined synopsis/solicitation for research and development services focused on vector-borne disease agent surveillance and external proficiency testing. This procurement seeks to advance the agency’s capabilities in monitoring, detecting, and responding to vector-borne disease threats through robust scientific research and the implementation of external proficiency testing programs.
The scope of this requirement encompasses comprehensive research and development activities in biotechnology, specifically excluding nanobiotechnology, as classified under NAICS code 541714. The primary objective is to enhance surveillance methodologies for vector-borne disease agents, ensuring that laboratory and field testing protocols meet high standards of accuracy and reliability. A critical component of the contract involves the development and administration of external proficiency testing, which is essential for validating the performance of laboratories engaged in disease agent detection and surveillance.
Key deliverables are expected to include detailed research findings, validated surveillance protocols, and the establishment or improvement of external proficiency testing frameworks. The contractor will be responsible for adhering to the performance work statement (PWS) and quality assurance surveillance plan (QASP) provided in the solicitation attachments. These documents outline the technical requirements, performance metrics, and quality standards that must be maintained throughout the contract lifecycle.
The place of performance for this effort is Maryland, United States. The procurement is not set aside for any specific business category, allowing for full and open competition among qualified offerors. The solicitation is active and has undergone two amendments: Amendment 0001 addressed an administrative change and included contractor Q&A, while Amendment 0002 consolidated additional contractor questions and answers and updated the contract specialist’s contact information.
The contracting activity is managed by the Defense Health Agency, with Benjamin Marcus ([email protected]) serving as the primary point of contact and Erin Maddox ([email protected]) as the secondary contact. Interested parties are encouraged to review all seven attachments available on the SAM.gov opportunity page for comprehensive details regarding the performance requirements and submission instructions.
This opportunity is classified under Product Service Code Q301, which pertains to medical- and laboratory-related research and development services. Contractors with expertise in biotechnology research, disease surveillance, and laboratory quality assurance are well-positioned to contribute to this critical public health mission. The solicitation remains open, with responses due by June 29, 2026.
For further information and to access the full solicitation package, including the PWS and QASP, interested contractors should visit the official SAM.gov listing at: https://sam.gov/opp/dd89d34312144902bc9cddae54fd7a95/view.
Documents7